TCS 3,447.35 +46.10 (1.36%) 
HDFCBANK 1,910.35 -6.00 (-0.31%) HINDUNILVR 2,331.60 +6.35 (0.27%) INFY 1,480.20 +8.90 (0.60%) HDFC 2,729.95 -17.05 (-0.62%) BHARTIARTL 1,815.60 -29.20 (-1.58%) KOTAKBANK 2,203.00 -21.00 (-0.94%) ICICIBANK 1,404.55 +2.30 (0.16%) ITC 428.15 -1.95 (-0.45%) BAJFINANCE 9,111.20 -186.90 (-2.01%) MARUTI 11,685.90 -214.90 (-1.81%) HCLTECH 1,579.30 -7.60 (-0.48%) SBIN 798.75 -14.45 (-1.78%) NESTLEIND 2,414.20 -20.60 (-0.85%) ASIANPAINT 2,430.20 -34.40 (-1.40%) WIPRO 240.80 -1.95 (-0.80%) DMART 4,373.55 -123.30 (-2.74%) AXISBANK 1,165.30 -42.00 (-3.48%) LT 3,272.15 -28.40 (-0.86%) HDFCLIFE 705.00 -3.20 (-0.45%) SUNPHARMA 1,786.85 -17.65 (-0.98%) ULTRACEMCO 12,236.20 +73.05 (0.60%) ONGC 246.35 -3.00 (-1.20%) BAJAJFINSV 2,045.35 -60.05 (-2.85%) BPCL 295.40 -6.55 (-2.17%) POWERGRID 306.25 -8.05 (-2.56%) TITAN 3,362.15 -22.20 (-0.66%) BRITANNIA 5,419.75 -43.80 (-0.80%) NTPC 356.30 -6.75 (-1.86%) Download Unicorn Signals App
By EquityPandit
Cadila Healthcare has received tentative approval to market Tadalafil tablets which are available in strengths of USP, 2.5 mg, 5 mg, 10 mg and 20 mg, from the USFDA.
The drug which has received approval is used to treat erectile dysfunction (impotence) and symptoms of benign prostatic hypertrophy (enlarged prostate). Further, it will be manufactured at the group’s manufacturing facility at Moraiya, Ahmedabad.
Read EquityPandit’s Technical Analysis of Indian Stock Market
